Roche lays out ac­cess am­bi­tions in its ESG strate­gies, in­clud­ing in­no­va­tion and val­ue goals

Roche laid out its am­bi­tions in the so­cial part of its en­vi­ron­men­tal, so­cial and gov­er­nance (ESG) strat­e­gy on Mon­day cen­tered on ac­cess to its drugs and di­ag­nos­tics.

The Roche in­au­gur­al Ac­cess to Health­care in­vestor call fol­lows a gen­er­al phar­ma in­dus­try trend in ESG. More com­pa­nies are pub­lish­ing re­ports and hold­ing calls to out­line cli­mate, so­ci­etal, di­ver­si­ty, and even pric­ing goals as in­vestors clam­or for de­tails amid surg­ing in­ter­est in ESG com­mit­ments.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.